Madrigal Pharmaceuticals (MDGL) Earnings Date, Estimates & Call Transcripts → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free MDGL Stock Alerts $220.06 +2.89 (+1.33%) (As of 05/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 7) -$7.38 Missed By -$1.32 Consensus EPS (May. 7) -$6.06 Read Call TranscriptListen to Call Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMDGL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MDGL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Madrigal Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($6.66)($5.82)($6.17)Q2 20243($8.36)($5.63)($7.16)Q3 20243($7.63)($4.91)($6.52)Q4 20243($6.43)($3.22)($5.10)FY 202412($29.08)($19.58)($24.94)MDGL Earnings Date and InformationMadrigal Pharmaceuticals last announced its earnings results on May 7th, 2024. The biopharmaceutical company reported ($7.38) earnings per share for the quarter, missing the consensus estimate of ($6.06) by $1.32. Madrigal Pharmaceuticals has generated ($23.09) earnings per share over the last year (($23.09) diluted earnings per share). Earnings for Madrigal Pharmaceuticals are expected to grow in the coming year, from ($27.62) to ($17.59) per share. Madrigal Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Madrigal Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 5/7/2024Q1 2024($6.06)($7.38)($1.32)($7.38)-- 2/28/2024Q4 2023($5.26)($5.68)($0.42)($5.68)--11/6/2023Q3 2023($4.90)($5.34)($0.44)($5.34)--8/8/2023Q2 2023($4.59)($4.69)($0.10)($4.69)--5/9/2023Q1 2023($4.78)($4.23)+$0.55($4.23)--2/23/2023Q4 2022($4.61)($4.98)($0.37)($4.98)--The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.11/3/2022Q3 2022($4.05)($4.75)($0.70)($4.75)--8/4/2022Q2 2022($3.76)($4.14)($0.38)($4.14)--5/9/2022Q1 2022($3.75)($3.36)+$0.39($3.36)-- 2/24/2022Q4 2021($3.92)($3.78)+$0.14($3.78)-- 11/4/2021Q3 2021($3.87)($3.79)+$0.08($3.79)--8/5/2021Q2 2021($3.58)($3.72)($0.14)($3.72)-- Madrigal Pharmaceuticals Earnings - Frequently Asked Questions When is Madrigal Pharmaceuticals's earnings date? Madrigal Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on MDGL's earnings history. Did Madrigal Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Madrigal Pharmaceuticals (NASDAQ:MDGL) missed the analysts' consensus estimate of ($6.06) by $1.32 with a reported earnings per share (EPS) of ($7.38). Learn more on analysts' earnings estimate vs. MDGL's actual earnings. How can I listen to Madrigal Pharmaceuticals's earnings conference call? The conference call for Madrigal Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Madrigal Pharmaceuticals's conference call transcript? The conference call transcript for Madrigal Pharmaceuticals's latest earnings report can be read online. Read Transcript How much profit does Madrigal Pharmaceuticals generate each year? Madrigal Pharmaceuticals (NASDAQ:MDGL) has a recorded net income of -$373.63 million. MDGL has generated -$23.09 earnings per share over the last four quarters. What is Madrigal Pharmaceuticals's EPS forecast for next year? Madrigal Pharmaceuticals's earnings are expected to grow from ($27.62) per share to ($17.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ALKS Earnings Date IONS Earnings Date FOLD Earnings Date GERN Earnings Date RCKT Earnings Date DVAX Earnings Date LGND Earnings Date IRWD Earnings Date MNKD Earnings Date YMAB Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:MDGL) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist My Default Watchlist Adding Madrigal Pharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.